CIK 0001710072
- Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821725586
- Phone
- +1 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $201,787
- in 1 filing
Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-12 | Carruthers R Michael Chief Financial Officer | Exercise or conversion | +5,781 | 87,590 | ||
| 2025-08-12 | Carruthers R Michael Chief Financial Officer | Sale | −1,428 | $13.39 | $19K | 86,162 |
| 2025-08-12 | Carruthers R Michael Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −5,781 | 17,344 | ||
| 2025-08-12 | Carruthers R Michael Chief Financial Officer | Grant or award · Restricted Stock Units | +26,875 | 26,875 | ||
| 2025-08-12 | Carruthers R Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +161,250 | 161,250 | ||
| 2025-05-02 | Carruthers R Michael Chief Financial Officer | Sale | −1,314 | $16.45 | $22K | 81,014 |
| 2025-05-01 | Carruthers R Michael Chief Financial Officer | Exercise or conversion | +5,209 | 82,328 | ||
| 2025-05-01 | Carruthers R Michael Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −5,209 | 0 | ||
| 2024-10-11 | Carruthers R Michael Chief Financial Officer | Exercise or conversion | +70,000 | $0.71 | $50K | 76,904 |
| 2024-10-11 | Carruthers R Michael Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −70,000 | 127,122 | ||
| 2024-09-20 | Carruthers R Michael Chief Financial Officer | Exercise or conversion | +46,068 | $1.93 | $89K | 81,996 |
| 2024-09-20 | Carruthers R Michael Chief Financial Officer | Sale | −46,068 | $28.59 | $1.3M | 35,928 |
| 2024-09-20 | Carruthers R Michael Chief Financial Officer | Sale | −4,064 | $28.59 | $116K | 31,864 |
| 2024-09-20 | Carruthers R Michael Chief Financial Officer | Sale | −24,960 | $28.59 | $714K | 6,904 |
| 2024-09-20 | Carruthers R Michael Chief Financial Officer | Exercise or conversion | +50,000 | $1.93 | $97K | 56,904 |
| 2024-09-20 | Carruthers R Michael Chief Financial Officer | Sale | −50,000 | $28.55 | $1.4M | 6,904 |
| 2024-09-20 | Carruthers R Michael Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −96,068 | 40,990 | ||
| 2024-08-12 | Carruthers R Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +138,750 | 138,750 | ||
| 2024-08-12 | Carruthers R Michael Chief Financial Officer | Grant or award · Restricted Stock Units | +23,125 | 23,125 | ||
| 2024-05-02 | Carruthers R Michael Chief Financial Officer | Sale | −2,157 | $18.91 | $41K | 35,230 |
Page 1 of 2 · 36 trades